10-Q Report Analysis
UnitedHealth Group's (UNH) 10-Q for the period ending September 30, 2024, reveals a mixed financial performance. While revenues showed growth, profitability was impacted by several factors, most notably the Change Healthcare cyberattack.
**Financial Performance:**
* **Revenue Growth:** Consolidated revenues increased by 9% year-over-year, driven by growth in both Optum and UnitedHealthcare segments. Optum, the company's health services segment, experienced a 13% revenue increase, primarily fueled by Optum Rx (pharmacy benefit management) and Optum Heal...
Cicada Financial Research Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Cicada Financial Research as a whole. Cicada Financial Research is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysis is generated using artificial intelligence and machine learning technologies to process market data and identify patterns. While we strive for accuracy, AI-generated analysis should be considered one of many factors in investment decision-making.
Register to read this report and the rest of our comprehensive and up to date premium analysis.
Technical Indicators
Advanced algorithmic analysis of price movements, volume patterns, and market trends delivered in real-time with actionable insights.
10K and 10Q Insights
Automated processing of financial statements and regulatory filings to extract key metrics and identify material changes that impact valuation.
Retail Sentiment
Comprehensive analysis of market sentiment from multiple sources, including subreddits like r/wallstreetbets and X.
Insider Activity
Real-time monitoring of insider transactions, institutional flows, and unusual trading patterns to identify significant market moves.
Copy link
Email